We are live on
!
Find out more
ACM
Ashford Capital Management Portfolio holdings
AUM
$809M
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$447M
AUM Growth
+$26.2M
(+6.2%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
39.1%
Holding
107
New
8
Increased
32
Reduced
41
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$3.4M |
| 2 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$2.49M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$2.4M |
| 4 |
Viasat
VSAT
|
+$2.25M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EBIX
Ebix Inc
EBIX
|
+$9.54M |
| 2 |
AMRI
Albany Molecular Research Inc
AMRI
|
+$6.23M |
| 3 |
NVEE
NV5 Global
NVEE
|
+$2.27M |
| 4 |
MarketAxess Holdings
MKTX
|
+$1.96M |
| 5 |
FLTX
Fleetmatics Group PLC
FLTX
|
+$1.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.98% |
| 2 | Industrials | 16.94% |
| 3 | Financials | 11.98% |
| 4 | Healthcare | 11.53% |
| 5 | Real Estate | 2.23% |
Similar funds
BDWCC
IPW
BWS
SSG
BBI
RPAM
PS
UAG
Ashford Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Ashford Capital Management held 107 positions worth $447M, up 6.2% from $421M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Ashford Capital Management's Q2 2016 filing shows 8 new, 32 increased, 41 reduced and 3 closed positions. Its largest new stake was Manhattan Associates: 54,600 shares worth $3.5M. The largest sale was Ebix Inc, an estimated $9.54M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- Ashford Capital Management's largest Q2 2016 buy was Manhattan Associates: 54,600 shares worth $3.5M.
- Ashford Capital Management added most to Medidata Solutions, Inc. in Q2 2016, an estimated $2.49M increase.
- Ashford Capital Management's biggest Q2 2016 reduction was Ebix Inc, cutting an estimated $9.54M.
- Ashford Capital Management fully exited Albany Molecular Research Inc in Q2 2016, selling an estimated $6.23M.
- Ashford Capital Management's ten largest holdings make up 39% of its $447M portfolio in Q2 2016.
- Ashford Capital Management opened 8 new positions and closed 3 in Q2 2016.
- Ashford Capital Management's portfolio value rose 6.2% quarter-over-quarter to $447M.
Based on Ashford Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.